HOME >> BIOLOGY >> NEWS
Other highlights in the January 4 JNCI

Virus-Drug Combination May Have Synergistic Effect Against Glioblastoma
A new study has found that a cancer drug and an engineered form of the herpes simplex virus may work together more effectively than either agent alone to destroy glioblastoma cells from human brain cancers.

The drug temozolomide, which stops tumor growth by preventing DNA replication in the cell, was approved in 2005 for the treatment of glioblastoma, a rapidly fatal type of brain cancer. However, some glioblastomas do not completely respond to this drug because the cancer cells repair DNA damage induced by the drug before the damage forces the cell to die.

Manish Aghi, M.D., Ph.D., of the Massachusetts General Hospital in Boston, and colleagues paired temozolomide with an oncolytic, or cancer killing, genetically engineered form of the herpes simplex virus called G207. They tested both agents together and separately in cancer cells and in mice with gliomas. Their laboratory studies on human cancer cells found that the virus and the drug act synergistically in cancer cells to promote cell death. Mice with brain gliomas treated with both the virus and the drug survived more than twice as long as those treated with either agent alone.

"Glioma treatment with temozolomide and G207, possibly giving temozolomide before inoculating virus during surgery to take advantage of temozolomide-induced DNA repair in residual glioma cells, warrants a clinical trial," the authors conclude.

Contact: Manish Aghi, Massachusetts General Hospital, 617-840-5111, maghi@partners.org

Autoimmune Disorders Associated with Risk of Non-Hodgkin Lymphoma
A new study confirms that certain autoimmune and inflammatory disorders are associated with an increased risk of non-Hodgkin lymphoma (NHL), a type of cancer that occurs in the lymphatic system. The study also examines the association between these disorde
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
3-Jan-2006


Page: 1 2 3 4

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
(Date:7/2/2020)... ... July 02, 2020 , ... Dutch ... the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 ... The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," ...
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now ... With 50 million stem cells total, patients may choose which extremities they would like ... arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... the leading global provider of advanced delivery technologies, development, and manufacturing solutions for ... they have entered into a strategic partnership whereby Catalent will provide support for ...
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information Solutions Life ... webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). , The ... medical devices, the NMPA has departments dealing with medical device registration (pre-market approvals) and ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Director of Clinical Research – Business Development. , Charles is an accomplished and ...
Breaking Biology Technology:
Cached News: